<DOC>
	<DOCNO>NCT02660606</DOCNO>
	<brief_summary>The purpose study evaluate patient usability reliability POMAQ survey evaluate opioid misuse abuse among adult chronic moderate severe pain , include patient opioid abuser , non-abusers , well non-opioid user</brief_summary>
	<brief_title>A Qualitative Study Assess Content Validity Prescription Opioid Misuse Abuse Questionnaire</brief_title>
	<detailed_description>The Food Drug Administration ( FDA ) request , part post-marketing requirement ( PMR ) new drug application ( NDA ) holder extend release/long-acting ( ER/LA ) opioids , conduct study develop validate measure opioid-related adverse event misuse abuse among patient chronic pain prescribe long-term opioid therapy . This measure use ass misuse abuse PMR Study 2065-1A PMR Study 2065-4B . Currently , tool exists meet need except Self-report Misuse , Abuse Diversion Prescription ( Rx ) Opioids questionnaire ( SR-MAD ) undergone several round prior content validation . The SR-MAD modify meet need PMR Studies 2065-1A 2065-4B , renamed Prescription Opioid Misuse Abuse Questionnaire ( POMAQ ) . This study seek develop validate POMAQ use Food Drug Administration ( FDA ) Guidance Industry , Patient-Reported Outcome Measures : Use Medical Product Development Support Labeling Claims ( FDA 2009 ) reference conduct qualitative research throughout process instrument development ensure content validity measure evaluate comprehensibility include question . This qualitative study evaluate content validity conduct prior quantitative study evaluate construct validity</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>1 . Age â‰¥ 18 year 2 . Patients , base Site Investigator 's clinical judgment , chronic moderate severe pain 3 . Willing provide write informed consent 4 . Able participate oneonone interview 5 . Able read , speak , understand English complete study assessment . 1 . Cognitive , psychiatric impairment base Site Investigator 's clinical judgment would interfere participate oneonone discussion 2 . Terminal illness life expectancy &lt; 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>